Literature DB >> 17979840

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.

Michael T Lotze1, Herbert J Zeh, Anna Rubartelli, Louis J Sparvero, Andrew A Amoscato, Newell R Washburn, Michael E Devera, Xiaoyan Liang, Mahmut Tör, Timothy Billiar.   

Abstract

The response to pathogens and damage in plants and animals involves a series of carefully orchestrated, highly evolved, molecular mechanisms resulting in pathogen resistance and wound healing. In metazoans, damage- or pathogen-associated molecular pattern molecules (DAMPs, PAMPs) execute precise intracellular tasks and are also able to exert disparate functions when released into the extracellular space. The emergent consequence for both inflammation and wound healing of the abnormal extracellular persistence of these factors may underlie many clinical disorders. DAMPs/PAMPs are recognized by hereditable receptors including the Toll-like receptors, the NOD1-like receptors and retinoic-acid-inducible gene I-like receptors, as well as the receptor for advanced glycation end products. These host molecules 'sense' not only pathogens but also misfolded/glycated proteins or exposed hydrophobic portions of molecules, activating intracellular cascades that lead to an inflammatory response. Equally important are means to not only respond to these molecules but also to eradicate them. We have speculated that their destruction through oxidative mechanisms normally exerted by myeloid cells, such as neutrophils and eosinophils, or their persistence in the setting of pathologic extracellular reducing environments, maintained by exuberant necrotic cell death and/or oxidoreductases, represent important molecular means enabling chronic inflammatory states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979840     DOI: 10.1111/j.1600-065X.2007.00579.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  253 in total

1.  Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials.

Authors:  Bryan N Brown; Ricardo Londono; Stephen Tottey; Li Zhang; Kathryn A Kukla; Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak
Journal:  Acta Biomater       Date:  2011-12-02       Impact factor: 8.947

Review 2.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

3.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 4.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 5.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

6.  Necrotroph attacks on plants: wanton destruction or covert extortion?

Authors:  Kristin Laluk; Tesfaye Mengiste
Journal:  Arabidopsis Book       Date:  2010-08-10

7.  Uric acid promotes an acute inflammatory response to sterile cell death in mice.

Authors:  Hajime Kono; Chun-Jen Chen; Fernando Ontiveros; Kenneth L Rock
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

8.  Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Authors:  Diana Groza; Sebastian Gehrig; Pavol Kudela; Martin Holcmann; Christine Pirker; Carina Dinhof; Hemma H Schueffl; Marek Sramko; Julia Hoebart; Fatih Alioglu; Michael Grusch; Manfred Ogris; Werner Lubitz; Bernhard K Keppler; Irena Pashkunova-Martic; Christian R Kowol; Maria Sibilia; Walter Berger; Petra Heffeter
Journal:  Oncoimmunology       Date:  2018-02-16       Impact factor: 8.110

Review 9.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

10.  HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Authors:  Celine Hernandez; Peter Huebener; Jean-Philippe Pradere; Daniel J Antoine; Richard A Friedman; Robert F Schwabe
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.